Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
Title |
Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| (00007885) A Randomized, Double-Blind, Placebo-Controlled Study of 4-Hydroxytamoxifen Topic Gel Among Women with Mammograpically Dense Breast - (Fixed Price) | Contract | $78,600.00 | Clinical Trial | Pavani Chalasani | Cancer Center Division | University of Texas: MD Anderson Cancer Center | 03/2020 |
| 2020 APSA West Regional Meeting | Contract | $173,800.00 | Other Sponsored Activity | Guy Reed | COM Phx Campus Administration | Arizona Department of Health Services | 12/2020 |
| 2020 ASH Hematology Opportunities for the Next-Generation of Research Scientists (HONORS) Award | Grant | $5,000.00 | Research | Jasmine Smith | Pediatrics | American Society of Hematology | 07/2020 |
| 4D Transcranial Acoustoelectric Imaging for High Resolution Functional Mapping of Neuronal Currents | Cooperative Agreement | $3,434,477.00 | Research | Russell Witte | Medical Imaging | National Institute of Biomedical Imaging and Bioengineering | 09/2020 |
| 5-HT1F Receptor Mediated Mitochondrial Biogenesis for The Treatment of Spinal Cord Injury | Fellowship | $112,449.00 | Research Training | Epiphani Simmons | Pharmacology and Toxicology | National Institute of Neurological Disorders and Stroke | 08/2020 |
| A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... | Contract | $314,050.00 | Clinical Trial | Chian Kwoh | Arthritis Center-Research | IQVIA RDS Inc. | 03/2020 |
| A Continuous Cancer Vaccine Platform Employing a Cell Based Implantable Device | Grant | $300,000.00 | Research | Emmanuel Katsanis | Pediatrics | Hyundai Hope on Wheels | 11/2020 |
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... | Contract | $105,851.40 | Clinical Trial | Aaron Wolfson | Sarver Heart Center | Cytokinetics, Incorporated | 09/2020 |
| A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies | Contract | $468,451.00 | Clinical Trial | Alejandro Recio Boiles | Cancer Center Division | Atreca, Inc. | 10/2020 |
| A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American men | Grant | $666,360.00 | Research training | David Garcia | Health Promotion Sciences | National Institute on Minority Health and Health Disparities | 02/2020 |
| A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells | Grant | $248,129.00 | Research | David Harris | UAHS Research | University of Pittsburgh | 07/2020 |
| A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19 | Contract | $254,412.60 | Clinical Trial | Billie Bixby | Medicine | Regeneron Pharmaceuticals, Inc | 10/2020 |
| A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 | Contract | $450,320.00 | Clinical Trial | Marilyn Glassberg Csete | COM Phx Internal Medicine | Regeneron Pharmaceuticals, Inc | 12/2020 |
| A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People with Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY) | Contract | $34,865.00 | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Seattle Children's Hospital | 11/2020 |
| A Mixed Method to Identify Causes of Kidney Cancer Surgical Disparities in Arizona | Grant | $388,482.00 | Research | Ken Batai | Surgery | National Cancer Institute | 06/2020 |
| A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS) | Contract | $167,627.92 | Clinical Trial | Christian Bime | Medicine | Kinevant Sciences, Inc. | 10/2020 |
| A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS.. | Contract | $168,927.92 | Clinical Trial | Marilyn Glassberg Csete | COM Phx Internal Medicine | Kinevant Sciences, Inc. | 08/2020 |
| A Multicenter Platform Evaluating Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults | Contract | $665,000.00 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Social & Scientific Systems, Inc | 12/2020 |
| A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion | Contract | $96,267.00 | Clinical Trial | Bellal Joseph | Surgery | Biogen Incorporated | 03/2020 |
| A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone... | Contract | $216,136.88 | Clinical Trial | Nancy Sweitzer | Sarver Heart Center | Syneos Health | 01/2021 |
| A Multicenter, Double-Blind, RanDomized, Placebo-Controlled, Parallel-Group Study to determine the EffIcacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects with Fabry Disease | Contract | $85,957.00 | Clinical Trial | Christina Laukaitis | Medicine | Idorsia Pharmaceutical (Switzerland) | 11/2020 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study on the Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC) | Contract | $173,775.50 | Clinical Trial | Deepak Acharya | Sarver Heart Center | Windtree Therapeutics, Inc. | 12/2020 |
| A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patie | Contract | $135,240.00 | Clinical Trial | Marilyn Glassberg Csete | COM Phx Internal Medicine | Brigham and Women's Hospital | 01/2021 |
| A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19... | Contract | $200,940.00 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Brigham and Women's Hospital | 11/2020 |
| A Novel Approach to Help Women of Reproductive Age Quit Smoking | Grant | $100,000.00 | Research | Alicia Allen | Family and Community Medicine | Prevent Cancer Foundation | 04/2020 |